NCT02345044View on ClinicalTrials.gov

A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Hypertensive Subjects

PHASE2CompletedINTERVENTIONAL

Enrollment

426

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

October 31, 2015

Conditions

Essential Hypertension

Interventions

DRUG

CS-3150

DRUG

placebo

DRUG

eplerenone

Trial Locations (1)

530-0001

Osaka

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Daiichi Sankyo

INDUSTRY